» Articles » PMID: 18256312

Activation of Podocytes by Mesangial-derived TNF-alpha: Glomerulo-podocytic Communication in IgA Nephropathy

Overview
Specialties Nephrology
Physiology
Date 2008 Feb 8
PMID 18256312
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously documented that human mesangial cell (HMC)-derived TNF-alpha is an important mediator involved in the glomerulo-tubular communication in the development of interstitial damage in IgA nephropathy (IgAN). With the strategic position of podocytes, we further examined the role of mesangial cells in the activation of podocytes in IgAN. There was no binding of IgA from patients with IgAN to podocytes. Podocytes cultured with IgA from patients with IgAN did not induce the release of growth factors or cytokines. Furthermore, podocytes did not express mRNA of known IgA receptors. In contrast, IgA-conditioned medium (IgA-HMC medium) prepared by culturing HMC with IgA from patients with IgAN for 48 h significantly increased the gene expression and protein synthesis of TNF-alpha by podocytes with a 17-fold concentration above that of IgA-HMC medium. The upregulation of TNF-alpha expression by podocyte was only abolished by a neutralizing antibody against TNF-alpha but not by other antibodies. Exogenous TNF-alpha upregulated the synthesis of TNF-alpha by podocytes in an autocrine fashion. IgA-HMC medium prepared with IgA from patients with IgAN also significantly upregulated the expression of both TNF-alpha receptor 1 and 2 in podocytes. Our in vitro finding suggests podocytes may play a contributory role in the development of interstitial damage in IgAN by amplifying the activation of tubular epithelial cells with enhanced TNF-alpha synthesis after inflammatory changes of HMC.

Citing Articles

Role of baseline soluble tumor necrosis factor receptor 2 as a biomarker in primary podocytopathy: Implications for renal impairment and disease progression.

Nagaram S, Charles P, Nisha Y, Stephen N, Hanumanthappa N, Parameswaran S BMC Nephrol. 2024; 25(1):378.

PMID: 39455940 PMC: 11515380. DOI: 10.1186/s12882-024-03772-y.


Serum soluble interleukin-2 receptor alpha may predict tubulointerstitial inflammatory cell infiltration and short-term disease progression in immunoglobin A nephropathy.

Xu C, Pan K, Li J, Li Y, Jin S, Shi Y Immunol Res. 2024; 72(6):1350-1364.

PMID: 39276201 PMC: 11618199. DOI: 10.1007/s12026-024-09533-1.


Contemporary review of IgA nephropathy.

Filippone E, Gulati R, Farber J Front Immunol. 2024; 15:1436923.

PMID: 39188719 PMC: 11345586. DOI: 10.3389/fimmu.2024.1436923.


Soluble Tumor Necrosis Factor Receptor 2: A Promising Predictive Biomarker for Renal Dysfunction in Membranous Glomerulonephritis.

Nagaram S, Charles P, Nandeesha H, Stephen N, Parameswaran S, Chinnakali P Cureus. 2024; 16(4):e58506.

PMID: 38765394 PMC: 11101981. DOI: 10.7759/cureus.58506.


Central role of podocytes in mediating cellular cross talk in glomerular health and disease.

Gujarati N, Chow A, Mallipattu S Am J Physiol Renal Physiol. 2024; 326(3):F313-F325.

PMID: 38205544 PMC: 11207540. DOI: 10.1152/ajprenal.00328.2023.